9 Results for "

glycaemic control

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "glycaemic control" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-109030
CAS No.: 1191995-00-2
Purity:  99.87%
Synonyms: HMS5552
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

Dorzagliatin (HMS5552), a dual-acting glucokinase (GK) activator, improves glycaemic control and pancreatic β-cell function in type 2 diabetes .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0231
CAS No.: 1088543-62-7
Target:  

GHSR

Research Areas:  

Metabolic Disease Endocrinology

AZP-531 is an analogue of unacylated ghrelin designed to improve glycaemic control and reduce weight.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2231
CAS No.: 1686108-82-6
Synonyms: MEDI0382
Target:  

GCGR

Research Areas:  

Metabolic Disease

Cotadutide (MEDI0382) is a potent dual agonist of glucagon-like peptide-1 (GLP-1) and GCGR with EC50 values of 6.9 pM and 10.2 pM, respectively. Cotadutide exhibits ability to facilitate both weight loss and glycaemic control, and alleviate fibrosis. Cotadutide can be used in the research of obesity and type 2 diabetes (T2D) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2231A
Synonyms: MEDI0382 acetate
Target:  

GCGR

Research Areas:  

Metabolic Disease

Cotadutide (MEDI0382) acetate is a potent dual agonist of glucagon-like peptide-1 (GLP-1) and GCGR with EC50 values of 6.9 pM and 10.2 pM, respectively. Cotadutide acetate exhibits ability to facilitate both weight loss and glycaemic control, and alleviate fibrosis. Cotadutide acetate can be used in the research of obesity and type 2 diabetes (T2D) .
loading...
    loading...
Cat. No.: HY-P0232
CAS No.: 116783-35-8
Synonyms: Fmoc-Thr(Ac₃AcNH-α-Gal)-OH
Research Areas:  

Inflammation/Immunology Cancer

AZP-531 is an analogue of unacylated ghrelin designed to improve glycaemic control and reduce weight.
loading...
    loading...
Cat. No.: HY-109556
CAS No.: 169148-63-4
Target:  

Akt ERK

Research Areas:  

Metabolic Disease

Insulin Detemir is an artificial insulin, shows effect on controlling blood sugar levels. Insulin Detemir stimulates GLP-1 secretion as a consequence of enhanced Gcg expression by a mechanism involving activation of Akt- and/or extracellular signal-regulated kinase (ERK)-dependent-cat and CREB signaling pathways. Insulin Detemir can be used for type 2 diabetes research .
loading...
    loading...
Cat. No.: HY-109030R
CAS No.: 1191995-00-2
Synonyms: HMS5552 (Standard)
Research Areas:  

Metabolic Disease

Dorzagliatin (Standard) is the analytical standard of Dorzagliatin. This product is intended for research and analytical applications. Dorzagliatin (HMS5552), a dual-acting glucokinase (GK) activator, improves glycaemic control and pancreatic β-cell function in type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P4062
CAS No.: 1200440-65-8
Synonyms: BIL
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Insulin peglispro (BIL) is a basal insulin with a flat, prolonged activity profile. Insulin peglispro can exhibit better glycaemic control compared to conventional insulins .
loading...
    loading...
Cat. No.: HY-121070
CAS No.: 871656-65-4
Target:  

Glucokinase

Research Areas:  

Metabolic Disease

AZD1092 is an orally active glucokinase (GK) activator with an EC50 value of 0.03 μM. AZD1092 can be used for the research of Type 2 Diabetes (T2D) .
loading...
    loading...